🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Squamous Cell Carcinoma of the Skin

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC NCT05085496Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Atezolizumab, Stereotactic Body Radiation Therapy A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors NCT05208762Phase 162 sites📍 Birmingham📍 Birmingham📍 Birmingham Seagen, a wholly owned subsidiary of Pfizer · Tests: PF-08046054, pembrolizumab TIL Therapy in cSCC and MCC NCT07288073Phase 21 site📍 Boston Karam Khaddour, MD, MS · Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors NCT07360314Phase 19 sites📍 New Haven📍 Huntersville📍 Galveston EMD Serono Research & Development Institute, Inc. · Tests: M7437, M7437 Cutaneous Squamous Cell Carcinoma Staging Study NCT05695222n/a2 sites📍 London📍 London Queen Mary University of London · Tests: This is not an interventional study Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence NCT06692556Phase 328 sites📍 Le Puy-en-Velay📍 Pierre-Bénite📍 Dijon Centre Leon Berard · Tests: Adjuvant radiotherapy Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma NCT07337161NA1 site📍 London David Palma · Tests: SBRT, Standard Radiation First in Human Study of TUB-030 in Patients With Advanced Solid Tumors NCT06657222Phase 1, Phase 220 sites📍 New Haven📍 Miami📍 Boston Gilead Sciences · Tests: TUB-030 Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study NCT07405086Phase 41 site📍 Portland OHSU Knight Cancer Institute · Tests: Biospecimen Collection, Immune Checkpoint Inhibitor A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites📍 New York📍 Huntersville📍 San Antonio Arvinas Inc. · Tests: ARV-6723, Pembrolizumab, SOC Towards Cure Via Only Ultra-short ICB in CSCC NCT06823479Phase 25 sites📍 Maastricht📍 Amsterdam📍 Amsterdam The Netherlands Cancer Institute · Tests: Nivolumab, Ipilumimab TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT06868433Phase 12 sites📍 Atlanta📍 Atlanta Emory University · Tests: Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography, Echocardiography, Magnetic Res… Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC NCT05741073n/a1 site📍 Brussels EuMelaReg gGmbH A Study of IDP-001 in Advanced or Metastatic Solid Tumors NCT07602842Phase 1, Phase 26 sites📍 Los Angeles📍 Sarasota📍 Indianapolis InduPro, Inc. · Tests: IDP-001 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors NCT06305962EARLY Phase 15 sites📍 Kingswood📍 Wollongong📍 Southport Radiopharm Theranostics, Ltd · Tests: 177Lu-RAD204 SUV PDL1/PD1 in Sun Damaged & Sun Protected Human Skin of Participants NCT06177106NA1 site📍 Tucson University of Arizona · Tests: Solar Simulated Light ctDNA in Cutaneous Squamous Cell Carcinoma NCT06875609n/a1 site📍 Boston Massachusetts Eye and Ear Infirmary · Tests: Blood and Tissue Collection IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation NCT06778863Phase 121 sites📍 Scottsdale📍 Tucson📍 Los Angeles Clasp Therapeutics, Inc. · Tests: CLSP-1025 Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma NCT06567314Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Ivonescimab Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors NCT06171750Phase 15 sites📍 Bethesda📍 Boston📍 Portland Ankyra Therapeutics, Inc · Tests: tolododekin alfa, Cemiplimab Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors NCT05985655Phase 1, Phase 215 sites📍 Los Angeles📍 Grand Rapids📍 New York Exscientia AI Ltd., a wholly owned subsidiary of Recursion … · Tests: GTAEXS617, SoC A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808Phase 115 sites📍 Denver📍 Sarasota📍 Detroit IDEAYA Biosciences · Tests: IDE034 Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis NCT07567235Phase 11 site📍 Chengdu West China Hospital · Tests: CFH Protein-loaded Ice Microneedles (0.5 mg), CFH Protein-loaded Ice Microneedles (1.0 mg), CFH Protein-loaded Ice Micr… PET-imaging of Two Vartumabs in Patients With Solid Tumors NCT06645808EARLY Phase 11 site📍 Groningen Var2 Pharmaceuticals · Tests: 89Zr-DFO-N-Suc-F8scFv, 89Zr-DFO-N-Suc-C9scFv, PET/CT scan (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma NCT05747625Phase 11 site📍 Nashville Eben Rosenthal · Tests: Panitumumab, Zirconium Zr 89 Panitumumab, Positron Emission Tomography, Computed Tomography, Electronic Health Record R… Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 NCT04787042Phase 1, Phase 26 sites📍 Scottsdale📍 Denver📍 New Haven Simcha IL-18, Inc. · Tests: ST-067, Obinutuzumab 25 MG/1 ML Intravenous Solution [GAZYVA], pembrolizumab Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors NCT07628634EARLY Phase 11 site📍 Orange University of California, Irvine · Tests: Methionine-Reduced Diet A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies NCT05669430Phase 1, Phase 213 sites📍 Los Angeles📍 Denver📍 New Haven GV20 Therapeutics · Tests: GV20-0251, GV20-0251, GV20-0251 and Pembrolizumab [KEYTRUDA®], GV20-0251 and Pembrolizumab [KEYTRUDA®] 5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer NCT05381597Phase 2, Phase 31 site📍 Boston Boston University · Tests: Combination cream of 5-fluorouracil and calcipotriene, 5-fluorouracil cream
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy